The Bloorview Research Institute's (BRI) Global Guest Speaker Series is a monthly virtual talk that brings international experts to share insights on childhood disability research, rehabilitation, and inclusion.

We are pleased to welcome Dr. Allyson Berent, Chief Science Officer; Foundation for Angelman Syndrome Therapeutics (FAST); Chief Development Officer AS2Bio; Co-Director Angelman Syndrome Biomarkers And Outcome Measures Consortium as our speaker for September.

Talk Title: The Patient Journey Through Drug Development: Making the Impossible Possible for Angelman Syndrome

Date & Time: Tuesday, September 15, 2026, 11:00 a.m. to 12:00 p.m. ET

Virtual event: Zoom

Moderator: Dr. Evdokia Anagnostou, vice president of research and director, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital